PD Neurotechnology develops medical devices for monitoring Parkinson's disease. Their product, PDMonitor, uses wearable devices to trace, record, and process symptoms commonly present in Parkinson's disease.

PD Neurotechnology

Neuraxpharm Pharmaceuticals, formerly known as Laboratorios Lesvi, is a pharmaceutical company that develops and manufactures medicines for the central nervous system (CNS) area.

Neuraxpharm Pharmaceuticals

PD Neurotechnology Ltd is a high-tech medical device company, founded in London, UK. The Greek Branch is based in Athens, Greece and the main activity of the company is carried out in the R&D and production, which is located in Ioannina, Greece. The company focuses its activities on researching, developing, producing and selling wearable medical devices and solutions for monitoring and supporting treatment of movement disorders. Its first solution is PDMonitor which is a sophisticated expert eco-system for patients with Parkinson’s Disease.

PD Neurotechnology Ltd.

The PD Neurotechnology® team enjoyed exploring the Plasmata II Art & Technology exhibition in Ioannina a few months ago.
 
Surrounded by innovative artworks, they bonded over shared experiences and were inspired by the profound digital art display.
 
Plasmata II was not just a cultural outing; it sparked innovation and unity within the team.
 
 #pdnculture #culture #art #PDNeurotechnology #event

We are delighted to share with you the updated guidelines by NICE for PDMonitor® adoption in the UK. 

#PDNeurotechnology #PDMonitor #parkinsons #parkinsonsdisease

🕯️Happy Easter! 
May this time of renewal and hope inspire you to cherish the wonders of life and share love and kindness with all those dear to you.

#HappyEaster #EasterWishes #Easter2024

On this World Parkinson's Day, let's join forces with those battling Parkinson's disease and stand by patients and caregivers in their daily efforts.

#PDMonitor, standing by you at every move you make.

#parkinsonsdisease #pdneurotechnology #worldparkinsonsday #pdmonitor #parkinson #parkinsons

On #WorldHealthDay2024, PD Neurotechnology extends its appreciation to the patients and their families, whose strength and resilience inspire us every day. We also express our gratitude to healthcare professionals worldwide, highlighting innovative #medicaltechnology such as #PDMonitor®. 

Designed to assist healthcare providers in monitoring and treating #ParkinsonsDisease patients globally, we stand united in support of your tireless dedication and invaluable contributions. 

#PDNeurotechonology #Parkinsons #ParkinsonsPatients #HealthForAll

PDNeurotechnology® wishes Merry Christmas and a Happy New Year to everyone!

Metric
Company Name	PD Neurotechnology	Neuraxpharm Pharmaceuticals
Symbol
MSH ID	COM:PDNEUROTECHNOLOGY	COM:LESVI
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical Devices	Pharmaceuticals
Country	GR	ES
Stage
Employee Count	23
Website	pdneurotechnology.com	lesvi.com
LinkedIn	pd-neurotechnology-ltd
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

PDNE

COM:PDNEUROTECHNOLOGY

PD Neurotechnology

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue